Intellectual Property net (Details) - USD ($) |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Feb. 29, 2024 |
Feb. 28, 2023 |
Aug. 31, 2023 |
|
| Balance - beginning | $ 462,625 | ||
| Impairment | (23,507) | $ 0 | |
| Balance - ending | 519,253 | $ 462,625 | |
| Patents [Member] | |||
| Balance - beginning | 462,625 | $ 488,462 | 488,462 |
| Addition | 97,016 | 135,862 | |
| Amortization | (16,881) | (54,938) | |
| Impairment | (23,507) | (106,761) | |
| Balance - ending | $ 519,253 | $ 462,625 | |
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accumulated amortization of intangible assets, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|